Related Experiment Videos
[Anti-arrhythmia and anti-lipid peroxidation effects of methylflavonolamine]
Abstract:
Effects of methylflavonolamine (MFA) on arrhythmias induced by myocardial reperfusion were studied with rat hearts in situ and in vitro. In pentobarbital-anesthetized rats, MFA (20 mg.kg-1, i.v.) pretreatment reduced the incidence of reperfusion-induced ventricular fibrillation after left descending coronary artery ligation (15 min) and reperfusion (3 min) (28.6% vs 85.7% in control, P less than 0.05). Malondialdehyde (MDA) production (85 +/- 9 nmol/g wet wt) was inhibited in myocardium from the reperfused area in comparison with control (133 +/- 15 nmol/g wet wt). In isolated rat hearts with local ischemia (15 min) and reperfusion (1 min), MFA 5 mumol.L-1 (perfused 10 min prior to coronary artery ligation) prevented reperfusion-induced arrhythmias (0% vs 85.7% in control, P less than 0.01). In myocardium from the reperfused area, superoxide dismutase (SOD) and catalase (Cat) activity was increased and xanthine oxidase (XOD) activity, MDA production and nonesterified fatty acids (NEFA) contents were decreased. The results show that MFA prevents reperfusion-induced arrhythmia by inhibiting lipid peroxidation and regulating the metabolism of NEFA.
Insights
Methylflavonolamine (MFA) effectively prevents heart arrhythmias caused by reperfusion injury. This compound reduces ventricular fibrillation and inhibits harmful lipid peroxidation, offering a potential therapeutic strategy.
Area of Science:
- Cardiovascular Pharmacology
- Biochemistry
- Cellular Physiology
Context:
- Myocardial reperfusion injury is a significant complication following ischemic events like heart attacks.
- Reperfusion can paradoxically trigger life-threatening arrhythmias and further tissue damage.
- Identifying protective agents against reperfusion-induced arrhythmias is crucial for improving patient outcomes.
Purpose:
- To investigate the antiarrhythmic effects of methylflavonolamine (MFA) on reperfusion-induced arrhythmias in rat hearts.
- To elucidate the underlying mechanisms by which MFA exerts its protective effects, focusing on oxidative stress and lipid metabolism.
Summary:
- Methylflavonolamine (MFA) significantly reduced the incidence of ventricular fibrillation in rats subjected to coronary artery ligation and reperfusion.
- In isolated hearts, MFA pretreatment completely prevented reperfusion-induced arrhythmias.
- MFA treatment decreased malondialdehyde production and nonesterified fatty acids, while increasing superoxide dismutase and catalase activity in the reperfused myocardium.
Impact:
- MFA demonstrates potent antiarrhythmic properties against myocardial reperfusion injury.
- The findings suggest MFA mitigates reperfusion damage by inhibiting lipid peroxidation and modulating fatty acid metabolism.
- MFA represents a promising therapeutic candidate for preventing arrhythmias associated with myocardial ischemia-reperfusion events.